An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the C.sub.max for the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a C.sub.max at different times.